Streetbeat News

Stock Prices

NFLX

Netflix, Inc. (NASDAQ:NFLX) stock is trading higher, with a nearly 6% increase over the past five days. The company announced it will have 86 games available by year-end, with 40 currently available and nearly 90 in development. Netflix also released its first 'What We Watched' viewership report to improve transparency and plans to release such reports biannually. Co-CEO Ted Sarandos emphasized the importance of accurate data for various stakeholders. NFLX is trading above its 50-day moving average and near its 52-week high.

Portfolio Pulse from Erica Kollmann

December 13, 2023 | 6:52 pm

OPTT

PGNT

Ocean Power Technologies, Inc. (OPTT) has sent a letter to shareholders urging them to vote 'FOR' all company proposals using the WHITE proxy card at the upcoming Annual Meeting on January 31, 2024. The letter emphasizes the company's transition from R&D to commercialization, particularly in national security and defense markets, and highlights recent contract wins and the goal of reaching profitability by 2025. OPTT's Board, with a majority of independent directors, is presented as having the right mix of experience to lead the company forward. Shareholders are advised to ignore materials from Paragon Technologies, Inc. (PGNT), as their nominees will not be counted following a court ruling.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:51 pm

HQY

Raymond James analyst C. Gregory Peters has reaffirmed an Outperform rating on HealthEquity (NASDAQ:HQY) and increased the price target from $90 to $95.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:49 pm

MDB

MongoDB (NASDAQ:MDB) has seen a balanced mix of bullish and bearish options activity, with 20 unusual trades split evenly between calls and puts. The options suggest a price target range of $310 to $490. Notable trades include bullish and bearish sentiments with various expiration dates and strike prices. MongoDB's stock is slightly up with a current price of $394.87 and may be nearing overbought territory. Analysts have set an average price target of $469.6, with ratings ranging from Neutral to Overweight and price targets between $420 and $500.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 6:47 pm

EWZ

USO

BP Energy has successfully won an oil auction for the concession of the Tupinamba area in Brazil's Santos Basin, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:45 pm

BITF

BTBT

CLSK

HIVE

MARA

RIOT

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:45 pm

CCCC

DESP

RSLS

STTK

TTWO

Despegar.com, Corp. (DESP) shares rose by 16.4% after raising its FY23 revenue guidance. Other stocks moved in Wednesday's mid-day session with significant gainers including Shattuck Labs (STTK), ReShape Lifesciences (RSLS), and C4 Therapeutics (CCCC), among others. Losers included Hywin Holdings (HYW), Boqii Holding (BQ), and Processa Pharmaceuticals (PCSA). Notable mentions include ABM Industries (ABM) with positive results and guidance, and Take-Two Interactive Software (TTWO) being added to the Nasdaq-100 Index.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 6:40 pm

ETH-USD

MATIC-USD

SPY

Former President Donald Trump's NFT collections have seen significant returns since their launch. The first collection, minted on the Polygon network and sold for $99 each, has appreciated to a value of $3,517.90 from an initial $1,000 investment, a 251.8% return in 12 months. This outperforms the S&P 500's 19.9% return over the same period. The second series of NFTs has not fared as well, with a current floor price resulting in a 35.8% loss for investors. A third 'MugShot Edition' collection has been announced, with a unique physical card component for bulk buyers and restrictions on transfer until December 31, 2024.

Portfolio Pulse from Chris Katje

December 13, 2023 | 6:39 pm

A significant options trade was detected for WW International, with a sweep of 1000 Jan 19 $7.5 call options at $0.95 each, compared to an open interest of 13956. The stock reference price at the time was $7.12.

Portfolio Pulse from Charles Gross

December 13, 2023 | 6:35 pm

ARCT

CSLLY

Canaccord Genuity initiated coverage on Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) with a bullish rating, citing the company's proprietary LNP delivery tech and mRNA cargos. They are particularly optimistic about ARCT-032, a cystic fibrosis treatment, which is in Phase 1b trials with interim data expected in H1 2024. A positive outcome could significantly revalue the program. Canaccord set a price target of $81, indicating over 200% upside. Arcturus is also advancing ARCT-810 for OTC deficiency, with Phase 2 trial enrollment underway. Additionally, ARCT-154, a COVID-19 vaccine developed with CSL Ltd (OTC:CSLLY), was approved in Japan. ARCT shares rose 4.07% to $24.29.

Portfolio Pulse from Vandana Singh

December 13, 2023 | 6:34 pm